DATAPHARM A/S: Financial statements 2019
CVR: 72323211
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -2,553,033 compared with DKK -2,485,439 the year before. Equity in the 2019 report amounted to DKK 7,990,707. The solvency ratio was 47.2%.
- Profit/Loss
- DKK -2,553,033
- Equity
- DKK 7,990,707
- Total Assets
- DKK 16,938,905
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -2.6 mio. | 8 mio. | - |
| 2018 | - | - | -2.5 mio. | 10.5 mio. | - |
| 2017 | - | 1.2 mio. | -2.5 mio. | 13 mio. | 1 |
| 2016 | - | 1.6 mio. | -2.3 mio. | 15.5 mio. | - |
| 2015 | - | 1.5 mio. | 1.1 mio. | 17.8 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
DATAPHARM A/S has published its annual report for 2018. The net result was DKK -2,485,439.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The board consists of Dan Asmussen (chair), Dorte Kamp Teglgård, Jonas Arendal Grønskov and Mia Bendix Andersen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees (2004). In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274.